Assertio Holdings, Inc. Share Price & Technical Analysis
ASRT · $23.44 (+0.30%)
Healthcare / Drug Manufacturers - Specialty & Generic
$23.44
+0.30%
Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provide…
Price chart
Seasonality
May has 5 positive and 0 negative years (last 5 years shown)
26% return in May, 10% avg return in past 3 year May month.
112% return in 2026, -46% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 28% | 0% | 62% | -5% | 26% | – | – | – | – | – | – | – | 112% |
| 25 | -9% | -2% | -13% | -4% | 1% | -3% | 15% | 20% | 6% | -16% | -3% | -16% | -23% |
| 24 | -19% | -2% | 10% | -8% | 13% | 22% | 12% | -15% | 2% | -14% | -3% | -14% | -17% |
| 23 | -5% | 33% | 13% | -13% | 15% | -15% | 4% | -42% | -23% | -16% | -53% | 4% | -97% |
| 22 | 18% | -10% | 25% | -27% | 43% | -3% | 32% | -35% | -11% | 13% | 17% | 39% | 102% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Strong · Exhausted
Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; and ROLVEDON, a long-acting granulocyte colony-stimulating factor that is indicated to decrease the incidence of infection caused by febrile neutropenia. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 2020 and is headquartered in Lake Forest, Illinois.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$144.82M
P/E ratio
—
52W high
$23.46
52W low
$8.61
Volume
2,84,880
Beta
0.45
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Assertio Holdings, Inc. share price today?
- Assertio Holdings, Inc. (ASRT) last traded around $23.44 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ASRT have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ASRT. Download the app for real-time alerts.
- How can I analyze Assertio Holdings, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.